<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-22-14</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-22-2-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Demyelinating Diseases</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Seroprevalence of Neuromyelitis Optica-IgG of Childhood Compared to Adults</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>02</month>
<year>2008</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>02</month>
<year>2016</year>
</pub-date>
<volume>22</volume>
<issue>2</issue>
<fpage>14</fpage>
<lpage>15</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2008 The Author(s)</copyright-statement>
<copyright-year>2008</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1212/01.wnl.0000284600.80782.d5" vol="70" page="344">
<article-title>Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The clinical and radiological characteristics and serostatus of neuromyelitis optica (NMO)-IgG in 87 children with inflammatory demyelinating CNS disorders were analyzed in a study at the Mayo Clinic, Rochester, MN, and other centers in the US, Canada, and Argentina.</p>
</abstract>
<kwd-group>
<kwd>Neuromyelitis Optica</kwd>
<kwd>NMO-Spectrum Disorder</kwd>
<kwd>Autoimmune Disease</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The clinical and radiological characteristics and serostatus of neuromyelitis optica (NMO)-IgG in 87 children with inflammatory demyelinating CNS disorders were analyzed in a study at the Mayo Clinic, Rochester, MN, and other centers in the US, Canada, and Argentina. Seventeen patients had NMO and of these, 8 (47%) were seropositive. The prevalence of seropositivity was higher with relapsing NMO (7 of 9, 78%) than monophasic NMO (1 of 8, 12.5%, p=0.01). The majority of children with NMO (14 of 17) were enrolled from the program in Argentina, and few came from Canada. None showed oligoclonal bands in the CSF. MRI abnormalities were revealed in 9 (53%). After a follow-up of 36 months (range 1.2-126 months), 6.3% children with NMO were wheelchair-bound and 23% had severe visual impairment. One of 5 children with relapsing optic neuritis and none of 8 with monophasic optic neuritis was seropositive. Among 41 with relapsing-remitting multiple sclerosis, 9 with transverse myelitis, and 3 with ADEM, none was seropositive. The frequency of NMO-IgG in children is similar to that in adults. Longitudinally extensive spinal lesions on MRI are not as predictive of NMO in children as in adults. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. Neuromyelitis optica is characterized by monophasic or recurrent episodes of optic neuritis and longitudinally extensive transverse myelitis, either monophasic or recurrent. The autoantibody NMO-IgG is present in 73% of adults with NMO and is 92% specific for NMO and related disorders, recurrent optic neuritis or transverse myelitis. In children with NMO in the above study, 47% were seropositive. The role of NMO-IgG autoantibody in NMO is unknown, but it may be important in recurrent disease. An overview of NMO in children is provided in an editorial. [<xref ref-type="bibr" rid="CIT0002">2</xref>]</p>
<p>The most useful diagnostic feature of NMO or NMO-spectrum disorders in adults is a longitudinally extensive spinal cord lesion. This contrasts with the well-circumscribed foci of increased T2-weighted signal in multiple sclerosis, typically seen in adults. In children with MS, the discrete spinal lesions are common, but 14% also show the longitudinally extensive spinal lesions, rare in adults with MS. A longitudinally extensive spinal lesion in a child with demyelinating disease does not exclude a diagnosis of MS and is less predictive of an NMO-spectrum disorder than in adult patients.</p>
<p><bold>Relationship between NMO and autoimmune disease.</bold> The association of NMO-IgG and non-organ-specific autoantibodies in patients with systemic lupus erythematosis (SLE) and in those with NMO spectrum disorder was evaluated at the Mayo Clinic and University of Lille, France [<xref ref-type="bibr" rid="CIT0003">3</xref>]. Patients with NMO were seropositive for NMO-IgG, and those with SLE without NMO were seronegative for this autoantibody. NMO-IgG is specific for distinguishing NMO spectrum disorder from multisystem autoimmune disorders. NMO may coexist with SLE and other autoimmune disease and is not a complication of SLE.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banwell</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tenembaum</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Ursell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bar-Or</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders</article-title>
<source>Neurology</source>
<year>2008</year>
<month>Jan</month>
<day>29</day>
<volume>70</volume>
<issue>5</issue>
<fpage>344</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000284600.80782.d5</pub-id>
<pub-id pub-id-type="pmid">18094334</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Finding NMO: neuromyelitis optica in children</article-title>
<source>Neurology</source>
<year>2008</year>
<month>Jan</month>
<day>29</day>
<volume>70</volume>
<issue>5</issue>
<fpage>334</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000298725.57899.fa</pub-id>
<pub-id pub-id-type="pmid">18227415</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pittock</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Lennon</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>de Seze</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vermersch</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Homburger</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Wingerchuk</surname>
<given-names>DM</given-names>
</name>
<etal/>
</person-group>
<article-title>Neuromyelitis optica and non organ-specific autoimmunity</article-title>
<source>Arch Neurol</source>
<year>2008</year>
<month>Jan</month>
<volume>65</volume>
<issue>1</issue>
<fpage>78</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2007.17</pub-id>
<pub-id pub-id-type="pmid">18195142</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>